Table 3.
Adjusted hazard ratio (HR) of mortality by status of cerebral palsy (CP) and non-trauma fracture (NTFx).
3-month mortality |
6-month mortality |
12-month mortality |
|
---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Reference: w/o CP w/o NTFx | |||
w/o CP + NTFx | 6.92 (6.70, 7.15) | 5.04 (4.91, 5.16) | 3.60 (3.53, 3.67) |
CP w/o NTFx | 4.33 (3.49, 5.36) | 3.76 (3.20, 4.42) | 3.31 (2.93, 3.74) |
CP + NTFx | 10.23 (7.80, 13.40) | 6.69 (5.28, 8.48) | 5.33 (4.42, 6.44) |
Reference: w/o CP + NTFx | |||
CP w/o NTFx | 0.62 (0.50, 0.77) | 0.75 (0.63, 0.88) | 0.92 (0.81, 1.04) |
CP + NTFx | 1.48 (1.13, 1.94) | 1.33 (1.05, 1.68) | 1.49 (1.24, 1.80) |
Reference: CP w/o NTFx | |||
CP + NTFx | 2.37 (1.68, 3.34) | 1.78 (1.34, 2.37) | 1.61 (1.29, 2.01) |
Adjusted for age, sex, US region, cardiovascular disease, respiratory disease, diabetes, chronic kidney disease, cancer, and hypertension.